Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: E9AJB6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.199 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.510 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.243 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.377 |
CLV_Separin_Metazoa | 41 | 45 | PF03568 | 0.334 |
DOC_MAPK_gen_1 | 23 | 32 | PF00069 | 0.340 |
DOC_USP7_UBL2_3 | 13 | 17 | PF12436 | 0.404 |
LIG_CtBP_PxDLS_1 | 29 | 35 | PF00389 | 0.335 |
MOD_PKA_1 | 53 | 59 | PF00069 | 0.389 |
TRG_Pf-PMV_PEXEL_1 | 7 | 12 | PF00026 | 0.243 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IZ21 | Bodo saltans | 68% | 100% |
A0A3S5H4U3 | Leishmania donovani | 86% | 100% |
A4H354 | Leishmania braziliensis | 80% | 100% |
A4HRF1 | Leishmania infantum | 86% | 100% |
A5JSS4 | Capra hircus | 62% | 100% |
B1MTI8 | Plecturocebus moloch | 62% | 100% |
C9ZXE6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 100% |
E9AC19 | Leishmania major | 86% | 100% |
O88892 | Mus musculus | 53% | 95% |
P84101 | Homo sapiens | 62% | 100% |
P84102 | Mus musculus | 62% | 100% |
Q32P76 | Bos taurus | 58% | 95% |
Q3E7B7 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 53% | 87% |
Q5R7C4 | Pongo abelii | 62% | 100% |
Q9BKU8 | Caenorhabditis elegans | 58% | 72% |
Q9VEW2 | Drosophila melanogaster | 54% | 98% |